Expertise in
14
conditions

Dr. Rebecca L. Aft

General Surgery
Barnes-Jewish Hospital
1 Barnes Jewish Hospital Plz, 
Saint Louis, MO 
Accepting New Patients
Expertise in
14
conditions
Barnes-Jewish Hospital
1 Barnes Jewish Hospital Plz, 
Saint Louis, MO 

Overview

Rebecca Aft is a General Surgeon practicing medicine in Saint Louis, Missouri.

Dr. Aft is highly rated in 14 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Inflammatory Breast Cancer, Paget Disease of the Breast, Mastectomy, and Lymphadenectomy.

She is actively involved in clinical research, co-authoring 76 peer reviewed articles and participating in 17 clinical trials. Dr. Aft is currently accepting new patients.

Specialties

General Surgery

Licenses

Surgery in MO

Hospital Affiliations

Barnes-Jewish West County Hospital
Barnes Jewish Hospital
Memorial Hospital
Missouri Baptist Medical Center

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Community Health Options
  • PPO
Cox Health
  • EPO
  • PPO
Essence Healthcare
  • INSURANCE PLAN
  • MEDICARE MAPD
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 10 Less Insurance Carriers -

Locations

Barnes-Jewish Hospital
1 Barnes Jewish Hospital Plz, Saint Louis, MO 63110

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

17 Clinical Trials

A Randomized Phase III Trial Comparing Axillary Lymph Node Dissection to Axillary Radiation in Breast Cancer Patients (cT1-3 N1) Who Have Positive Sentinel Lymph Node Disease After Neoadjuvant Chemotherapy
A Randomized Phase III Trial Comparing Axillary Lymph Node Dissection to Axillary Radiation in Breast Cancer Patients (cT1-3 N1) Who Have Positive Sentinel Lymph Node Disease After Neoadjuvant Chemotherapy
Enrollment Status: Active_not_recruiting
Publish Date: August 31, 2026
Intervention Type: Radiation, Procedure
Study Phase: Phase 3
Phase Ib/II Study to Evaluate Safety and Tolerability of Neoadjuvant Nivolumab and Chemotherapy in Patients With Localized Triple-negative Breast Cancer
Phase Ib/II Study to Evaluate Safety and Tolerability of Neoadjuvant Nivolumab and Chemotherapy in Patients With Localized Triple-negative Breast Cancer
Enrollment Status: Terminated
Publish Date: July 09, 2026
Intervention Type: Drug, Procedure, Biological
Study Drugs: Paclitaxel, Carboplatin, Nivolumab, Cabiralizumab
Study Phase: Phase 1/Phase 2
Effect of Preoperative Breast MRI on Surgical Outcomes, Costs and Quality of Life of Women With Breast Cancer
Effect of Preoperative Breast MRI on Surgical Outcomes, Costs and Quality of Life of Women With Breast Cancer
Enrollment Status: Completed
Publish Date: June 26, 2026
Intervention Type: Procedure
Study Phase: Phase 3
A Phase 1B Clinical Trial to Evaluate the Safety and Immune Response to a Mammaglobin-A DNA Vaccine in ER+, HER2- Breast Cancer Patients Undergoing Neoadjuvant Endocrine Therapy or Chemotherapy
A Phase 1B Clinical Trial to Evaluate the Safety and Immune Response to a Mammaglobin-A DNA Vaccine in ER+, HER2- Breast Cancer Patients Undergoing Neoadjuvant Endocrine Therapy or Chemotherapy
Enrollment Status: Active_not_recruiting
Publish Date: April 21, 2026
Intervention Type: Biological, Procedure
Study Drug: Mammaglobin-A DNA Vaccine
Study Phase: Phase 1
EMBER-2: A Phase 1, Open-Label, Preoperative Window Study Evaluating the Biological Effects of LY3484356 in Post-menopausal Women With Stage I-III Estrogen Receptor-Positive, HER2-Negative Breast Cancer
EMBER-2: A Phase 1, Open-Label, Preoperative Window Study Evaluating the Biological Effects of LY3484356 in Post-menopausal Women With Stage I-III Estrogen Receptor-Positive, HER2-Negative Breast Cancer
Enrollment Status: Completed
Publish Date: November 12, 2025
Intervention Type: Drug
Study Drug: LY3484356
Study Phase: Phase 1
Evaluation of LS301 Uptake in Tumors of Patients Undergoing Partial Mastectomy and Sentinel Lymph Node Biopsy for Breast Cancer
Evaluation of LS301 Uptake in Tumors of Patients Undergoing Partial Mastectomy and Sentinel Lymph Node Biopsy for Breast Cancer
Enrollment Status: Terminated
Publish Date: August 17, 2025
Intervention Type: Drug, Procedure, Device
Study Drug: LS301
Study Phase: Phase 1/Phase 2
Randomized Double-Blind Placebo Controlled Study of Testosterone in the Adjuvant Treatment of Postmenopausal Women With Aromatase Inhibitor Induced Arthralgias
Randomized Double-Blind Placebo Controlled Study of Testosterone in the Adjuvant Treatment of Postmenopausal Women With Aromatase Inhibitor Induced Arthralgias
Enrollment Status: Completed
Publish Date: January 28, 2025
Intervention Type: Other, Drug
Study Phase: Phase 3
A Large-scale Multicenter Phase II Study Evaluating the Protective Effect of a Tissue Selective Estrogen Complex (TSEC) in Women With Newly Diagnosed Ductal Carcinoma in Situ
A Large-scale Multicenter Phase II Study Evaluating the Protective Effect of a Tissue Selective Estrogen Complex (TSEC) in Women With Newly Diagnosed Ductal Carcinoma in Situ
Enrollment Status: Completed
Publish Date: January 28, 2025
Intervention Type: Other, Procedure, Drug
Study Drug: Conjugated Estrogens/Bazedoxifene
Study Phase: Phase 2
PECS Block vs. Multimodal Analgesia for Prevention of Persistent Postoperative Pain in Breast Surgery
PECS Block vs. Multimodal Analgesia for Prevention of Persistent Postoperative Pain in Breast Surgery
Enrollment Status: Completed
Publish Date: December 24, 2024
Intervention Type: Drug
Study Phase: Phase 2
A Randomized Phase 1 Trial of Neoantigen DNA Vaccine Alone vs. Neoantigen DNA Vaccine Plus Durvalumab in Triple Negative Breast Cancer Patients Following Standard of Care Therapy
A Randomized Phase 1 Trial of Neoantigen DNA Vaccine Alone vs. Neoantigen DNA Vaccine Plus Durvalumab in Triple Negative Breast Cancer Patients Following Standard of Care Therapy
Enrollment Status: Terminated
Publish Date: May 28, 2024
Intervention Type: Device, Biological, Drug, Procedure
Study Drugs: Durvalumab, Neoantigen DNA vaccine
Study Phase: Phase 1
View 9 Less Clinical Trials

76 Total Publications

ASO Visual Abstract: A Prospective, Multi-Center Randomized Controlled Trial (RCT) of the da Vinci SP Surgical System Versus Open Surgery in Nipple Sparing Mastectomy (NSM) Procedures for Patients with Breast Cancer.
ASO Visual Abstract: A Prospective, Multi-Center Randomized Controlled Trial (RCT) of the da Vinci SP Surgical System Versus Open Surgery in Nipple Sparing Mastectomy (NSM) Procedures for Patients with Breast Cancer.
Journal: Annals of surgical oncology
Published: July 23, 2026
Similar Doctors
Expertise in
36
conditions
Dr. Ryan C. Fields
General Surgery
Expertise in
36
conditions
Dr. Ryan C. Fields
General Surgery
Referral may be required
Before you request

Washington University

660 S Euclid Ave, 
Saint Louis, MO 
 (0.2 miles away)
314-286-1694
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Ryan Fields is a General Surgeon practicing medicine in Saint Louis, Missouri. Dr. Fields is highly rated in 36 conditions, according to our data. His clinical expertise encompasses Neuroendocrine Tumor, Pancreatic Cancer, Gallbladder Cancer, Pancreaticoduodenectomy, and Pancreatectomy. Dr. Fields is currently accepting new patients.

Expertise in
20
conditions
Dr. Steven M. Strasberg
General Surgery
Expertise in
20
conditions
Dr. Steven M. Strasberg
General Surgery
Referral may be required

Washington University

660 S Euclid Ave, 
Saint Louis, MO 
 (0.2 miles away)
314-362-7147
Languages Spoken:
English

Steven Strasberg is a General Surgeon practicing medicine in Saint Louis, Missouri. Dr. Strasberg is highly rated in 20 conditions, according to our data. His clinical expertise encompasses Gallbladder Disease, Cholecystitis, Pancreatic Cancer, Gallbladder Removal, and Hepato-Pancreato-Biliary Surgery.

Expertise in
14
conditions
Expertise in
14
conditions
Referral may be required

Barnes Jewish West County Hospital

12634 Olive Blvd, 
Saint Louis, MO 
 (11.3 miles away)
314-996-8000
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Julie Margenthaler is a General Surgeon practicing medicine in Saint Louis, Missouri. Dr. Margenthaler is highly rated in 14 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Intraductal Papilloma, Mastectomy, and Lymphadenectomy. Dr. Margenthaler is currently accepting new patients.

Frequently Asked Questions about Dr. Rebecca L. Aft

How do I make an appointment with Dr. Rebecca L. Aft?

You can book an appointment with Dr. Rebecca L. Aft by calling their office at 314-362-5000. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Rebecca L. Aft a top-rated expert for Breast Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Rebecca L. Aft is classified as an Elite expert for Breast Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Rebecca L. Aft specialize in?

While Dr. Rebecca L. Aft is a General Surgery, they have specific expertise in Breast Cancer, Inflammatory Breast Cancer, and Paget Disease of the Breast. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within General Surgery.

Does Dr. Rebecca L. Aft participate in research or clinical trials?

Yes. Dr. Rebecca L. Aft has published 76 articles and abstracts on conditions like Breast Cancer. You can view a list of Dr. Rebecca L. Aft's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Rebecca L. Aft accept my insurance?

Dr. Rebecca L. Aft accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 314-362-5000 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Aft's expertise for a condition
ConditionClose
View All 9 Advanced Conditions
View All 21 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile